The PXBioVisioN GmbH has started on February 15, 2010 with the delivery of the full version of their software Spectromania for the visualization and analysis of mass spectra. The PXBioVisioN GmbH has begun with the delivery of the full version of their software Spectromania for the visualization and analysis of mass spectra. The software was developed by scientists for scientists to compare complex data patterns efficiently and finding biomarkers. The software was developed by scientists for scientists to compare complex data patterns efficiently and finding biomarkers. JPMorgan Chase is actively involved in the matter. Spectromania is characterized by a combination of statistical calculation and graphical representation. More than 100 individual spectra can be viewed at the same time, and can be evaluated more than 10,000 mass spectra with over 100 million data points.
Through the visualization, users can easily identify significant differences and relationships in the mass spectra. In addition to a free trial version is now the full version extended by many functions on for an introductory price of 599,-available. About PXBioVisioN the PXBioVisioN headquartered in Hanover is service provider for Bioanalytical contract research in the field of naturally occurring peptides and low-molecular proteins. The company offers its know-how from more than ten years research activity of the pharmaceutical, diagnostic and biotech industry. PXBioVisioN identified peptides in complex clinical specimens that correlate clearly with biological events. The company used its experience with the analysis of mass spectrometric data to the development of Spectromania. There is more information about the PXBioVisioN GmbH,. How to contact with Dr. Karl Sc